Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: The Role of Apathy in Glycemic Control [NA]
This update describes results from a completed clinical trial investigating the role of apathy in managing blood glucose among people with d…
-
CLINICAL_TRIALS research · 2014-04-21Clinical Trial Update: Impact of Peer Support on Diabetes in China [NA]
This document reports a clinical trial update on the impact of peer support on diabetes management in China. The status is listed as UNKNOWN…
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic [Phase 3]
A Phase 3 clinical trial evaluating strategies to sustain control of cardiac risk factors after discharge from a cardiovascular risk reducti…
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Residual Gastric Volume in Morbidly Obesa Diabetics. A Comparison of 3 Hour Versus Hour Fasting. [NA]
A completed clinical trial comparing 3-hour vs 1-hour fasting and its effect on residual gastric volume in morbidly obese individuals with d…
-
FDA approval · 2014-04-11FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company. The action updates the product's label…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-04-11FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) from Eli Lilly and Company. The action relates to …
-
FDA approval · 2014-04-11FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly, supporting changes to the product related to the supplemental…
-
FDA approval · 2014-04-11FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin 70/30 (insulin human) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Efficacy Of CACIPLIQ20 On Diabetic Ulcers In Patients Wearing An Nonremovable, Windowed, Fiberglass Cast Boot [NA]
A completed clinical trial evaluating the efficacy of CACIPLIQ20 for diabetic foot ulcers in patients wearing a nonremovable fiberglass cast…
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Evaluation of Blood Glucose Monitoring Systems With Blood Samples From Neonates [NA]
A completed clinical trial evaluated blood glucose monitoring systems using blood samples from neonates; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF [Phase 1, Phase 2]
An open-label Phase I/II trial evaluating CD133+ cells mobilized with G-CSF for therapeutic angiogenesis in diabetic patients with critical …
-
FDA approval · 2014-04-03FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly, indicating approval of changes supported by the su…
-
FDA approval · 2014-04-03FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) from Eli Lilly and Company. This action updates th…
-
FDA approval · 2014-04-03FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin 70/30 (insulin human) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: Adopting a Physically Active Lifestyle Through Organized Walk Events Among Joslin Clinic Patients [NA]
The clinical trial NCT01888133 at Joslin Diabetes Center investigating whether organized walking events promote a physically active lifestyl…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: The Effects of RVX000222 on Glucose Metabolism in Individuals With Pre-diabetes [Phase 2]
This is a Phase 2 trial update assessing the effects of RVX000222 on glucose metabolism in individuals with prediabetes. The study has compl…
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: Identifying and Overcoming Barriers to Diabetes Management in the Elderly: An Intervention Study [NA]
This completed intervention study investigated barriers to diabetes management in elderly individuals and explored strategies to improve adh…
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: Identifying and Overcoming Barriers to Diabetes Management in the Elderly: A Cost-effective Intervention Study [NA]
This completed clinical trial evaluated barriers to diabetes management in older adults and tested cost-effective intervention strategies. T…
-
CLINICAL_TRIALS trial_result · 2014-03-24Clinical Trial Update: Comparison of New-onset Diabetes After Transplantation Between Two Steroid Withdrawal Group With CellCept [NA]
Clinical trial update comparing two steroid-withdrawal regimens in transplant patients receiving CellCept, focusing on new-onset diabetes af…
-
CLINICAL_TRIALS trial_result · 2014-03-24Clinical Trial Update: Technological Rehabilitation of Distal Sensorimotor Polyneuropathy in Diabetic Patients [NA]
Clinical trial NCT01926522 evaluating technological rehabilitation for distal sensorimotor polyneuropathy in diabetic patients has completed…
-
FDA approval · 2014-03-18FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly and Company.
-
FDA approval · 2014-03-18FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro), manufactured by Eli Lilly and Company.
-
FDA approval · 2014-03-18FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN R (insulin human) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Trial Comparing Care in Multiple Clinics Versus Care in a Cardiac, Diabetes and Kidney Care Clinic [NA]
This completed trial compared care delivered across multiple clinics with care provided in a dedicated Cardiac, Diabetes and Kidney Care Cli…
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Mortality Follow-Up and Analyses of Men in the MRFIT
This update presents mortality follow-up and analyses from the male participants in the Multiple Risk Factor Intervention Trial (MRFIT).